Analyzing the Future of Heart Defect Closure Device Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the heart defect closure device market right now?
The market size for heart defect closure devices has seen swift expansion in the past few years. It is projected to rise from $1.11 billion in 2024 to $1.27 billion in 2025, escalating at a compound annual growth rate (CAGR) of 14.5%. The historic growth of this market can be linked to the increase in individuals suffering from congenital heart disorders, an ageing demographic, enhanced health consciousness, intensifying research and development efforts, and advancements in the techniques of catheterization.
How fast Is the heart defect closure device market expected to grow, and what’s its future value?
The market size of heart defect closure devices is anticipated to experience a rapid expansion in the forthcoming years, reaching $2.17 billion by 2029, with a compound annual growth rate (CAGR) of 14.2%. This projected growth during the forecast timeframe is likely due to an increase in congenital defects, enhanced diagnostic methods, a heightened utilization of MRI procedures, an upsurge in the application of 3D imaging in heart defect closure protocols, and a high incidence rate of ischemic stroke. Significant trends to watch over this forecast period comprise technological progress, the creation of cutting-edge products, the invention of advanced heart closure devices, the escalating detection of PFO closure devices, and the requisite to gauge the advantages of PFO closure in the elderly demographic.
Get your heart defect closure device market report here!
https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report
What are the leading drivers of growth in the heart defect closure device market?
The heart defect closure device market is anticipated to expand due to the increasing cases of congenital heart defects. These refer to heart structure abnormalities present since birth. Genetic factors, environmental influences, and maternal health conditions like diabetes, obesity, and exposure to certain drugs or infections during pregnancy all contribute to the rise in these defects. Heart defect closure devices provide a less invasive way to close abnormal heart openings, subsequently restoring regular blood flow, minimizing complications, and enhancing overall heart function. Citing an instance, an article in the National Library of Medicine (NLM), a US-based entity specialising in biomedical informatics and computational health data research reported a steep increase in CHD incidence rates moving from 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022, to 5.46% in 2023. Thus, the escalating cases of congenital heart defects are fueling the growth of the heart defect closure device market.
What are the key segments defining the heart defect closure device market?
The heart defect closure device market covered in this report is segmented –
1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp
Who are the key players steering the development of the heart defect closure device market?
Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Coherex Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.
What key trends are currently impacting the heart defect closure device market’s development?
In an effort to offer minimally invasive solutions for heart defect closures, leading players in the heart defect closure device market are focusing on the advancement of self-expanding, double-disc occluders. These innovative devices come with potential benefits including safer procedures, quicker patient recovery, and a decreased likelihood of complications as compared to conventional open-heart surgeries. Illustrating this in September 2022, US-based medical and healthcare company, Abbott Laboratories, introduced the Amplatzer Talisman PFO Occlusion System in Europe. Intended for closing a patent foramen ovale (PFO) – an unusual opening between the heart’s left and right atria that may lead to strokes or other complications – this system uses a minimally invasive method. It employs a self-expanding, double-disc occluder composed of nitinol wire mesh, thereby efficiently securing the PFO and blocking clot passage between the atria.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16074
Which regions are most influential in expanding the heart defect closure device market?
North America was the largest region in the heart defect closure device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Prosthetic Heart Valve Devices And Equipment Global Market Report 2024
Hearth Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hearth-global-market-report
Heart Pump Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
